Literature DB >> 16772923

Tissue-engineered axially vascularized contractile skeletal muscle.

Gregory H Borschel1, Douglas E Dow, Robert G Dennis, David L Brown.   

Abstract

BACKGROUND: As tissue-engineered muscle constructs increase in scale, their size is limited by the need for a vascular supply. In this work, the authors demonstrate a method of producing three-dimensional contractile skeletal muscles in vivo by incorporating an axial vascular pedicle.
METHODS: Primary myoblast cultures were generated from adult F344 rat soleus muscle. The cells were suspended in a fibrinogen hydrogel contained within cylindrical silicone chambers, and situated around the femoral vessels in isogeneic adult recipient rats. The constructs were allowed to incubate in vivo for 3 weeks, at which point they were explanted and subjected to isometric force measurements and histologic evaluation.
RESULTS: The resulting three-dimensional engineered skeletal muscle constructs produced longitudinal contractile force when electrically stimulated. Length-tension, force-voltage, and force-frequency relationships were similar to those found in developing skeletal muscle. Desmin staining demonstrated that individual myoblasts had undergone fusion to form multinucleated myotubes. Von Willebrand staining showed that the local environment within the chamber was richly angiogenic, and capillaries had grown into and throughout the constructs from the femoral artery and vein.
CONCLUSIONS: Three-dimensional, vascularized skeletal muscle can be engineered in vivo. The resulting tissues have histologic and functional properties consistent with native skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16772923     DOI: 10.1097/01.prs.0000224295.54073.49

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  21 in total

Review 1.  Engineering orthopedic tissue interfaces.

Authors:  Peter J Yang; Johnna S Temenoff
Journal:  Tissue Eng Part B Rev       Date:  2009-06       Impact factor: 6.389

2.  A novel in vitro three-dimensional skeletal muscle model.

Authors:  Michele L Marquette; Diane Byerly; Marguerite Sognier
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-09-05       Impact factor: 2.416

3.  The surface molecular functionality of decellularized extracellular matrices.

Authors:  Christopher A Barnes; Jeremy Brison; Roger Michel; Bryan N Brown; David G Castner; Stephen F Badylak; Buddy D Ratner
Journal:  Biomaterials       Date:  2010-11-04       Impact factor: 12.479

Review 4.  Striated muscle function, regeneration, and repair.

Authors:  I Y Shadrin; A Khodabukus; N Bursac
Journal:  Cell Mol Life Sci       Date:  2016-06-06       Impact factor: 9.261

Review 5.  Establishing Early Functional Perfusion and Structure in Tissue Engineered Cardiac Constructs.

Authors:  Bo Wang; Sourav S Patnaik; Bryn Brazile; J Ryan Butler; Andrew Claude; Ge Zhang; Jianjun Guan; Yi Hong; Jun Liao
Journal:  Crit Rev Biomed Eng       Date:  2015

Review 6.  Engineering skeletal muscle repair.

Authors:  Mark Juhas; Nenad Bursac
Journal:  Curr Opin Biotechnol       Date:  2013-05-24       Impact factor: 9.740

Review 7.  Tissue engineering of functional skeletal muscle: challenges and recent advances.

Authors:  Weining Bian; Nenad Bursac
Journal:  IEEE Eng Med Biol Mag       Date:  2008 Sep-Oct

Review 8.  Engineered matrices for skeletal muscle satellite cell engraftment and function.

Authors:  Woojin M Han; Young C Jang; Andrés J García
Journal:  Matrix Biol       Date:  2016-06-04       Impact factor: 11.583

9.  Structural and biomechanical characterizations of porcine myocardial extracellular matrix.

Authors:  Bo Wang; Mary E Tedder; Clara E Perez; Guangjun Wang; Amy L de Jongh Curry; Filip To; Steven H Elder; Lakiesha N Williams; Dan T Simionescu; Jun Liao
Journal:  J Mater Sci Mater Med       Date:  2012-05-15       Impact factor: 3.896

Review 10.  Hydrogel biomaterials and their therapeutic potential for muscle injuries and muscular dystrophies.

Authors:  Rachel Lev; Dror Seliktar
Journal:  J R Soc Interface       Date:  2018-01       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.